Terug
Dagbereik
€ 9,46
€ 10,77
52-Weeksbereik
€ 9,46
€ 23,85
Volume
400
50D / 200D Gem.
€ 15,11
/
€ 17,62
Vorige Slotkoers
€ 9,46
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 22,8 | 0,4 |
| P/B | 2,1 | 2,9 |
| ROE % | 8,5 | 3,7 |
| Net Margin % | 3,8 | 3,8 |
| Rev Growth 5Y % | 5,3 | 10,0 |
| D/E | 1,5 | 0,2 |
Belangrijkste Punten
Revenue grew 5,30% annually over 5 years — modest growth
Earnings declined -37,20% over the past year
Negative free cash flow of 0,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,90%
Groei
Revenue Growth (5Y)
5,30%
Revenue (1Y)-0,60%
Earnings (1Y)-37,20%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
8,50%
ROIC5,90%
Net Margin3,81%
Op. Margin8,31%
Veiligheid
Debt / Equity
1,53
Current Ratio0,52
Interest Coverage3,23
Waardering
P/E Ratio
22,79
P/B Ratio2,09
EV/EBITDA18,16
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,60% | Revenue Growth (3Y) | 2,94% |
| Earnings Growth (1Y) | -37,20% | Earnings Growth (3Y) | -23,29% |
| Revenue Growth (5Y) | 5,30% | Earnings Growth (5Y) | -12,78% |
| Profitability | |||
| Revenue (TTM) | 2,39B | Net Income (TTM) | 91,30M |
| ROE | 8,50% | ROA | 2,56% |
| Gross Margin | 8,31% | Operating Margin | 8,31% |
| Net Margin | 3,81% | Free Cash Flow (TTM) | 0,0 |
| ROIC | 5,90% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,53 | Current Ratio | 0,52 |
| Interest Coverage | 3,23 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 22,79 | P/B Ratio | 2,09 |
| P/S Ratio | 0,87 | PEG Ratio | -0,88 |
| EV/EBITDA | 18,16 | Dividend Yield | 0,02% |
| Market Cap | 2,08B | Enterprise Value | 3,61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,39B | 2,41B | 2,26B | 2,12B | 1,95B |
| Net Income | 91,30M | 145,37M | 155,14M | 178,53M | 157,79M |
| EPS (Diluted) | 0,40 | 0,64 | 0,69 | 0,79 | 0,69 |
| Gross Profit | 198,94M | 1,36B | 548,45M | 275,71M | 259,56M |
| Operating Income | 198,94M | 256,81M | 259,21M | 275,71M | 259,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,56B | 3,99B | 3,69B | 3,58B | 3,52B |
| Total Liabilities | 2,57B | 2,84B | 2,59B | 2,54B | 2,59B |
| Shareholders' Equity | 997,84M | 1,15B | 1,10B | 1,04B | 925,18M |
| Total Debt | 1,53B | 1,72B | 1,52B | 1,51B | 1,61B |
| Cash & Equivalents | 0,0 | 288,83M | 193,15M | 179,65M | 268,55M |
| Current Assets | 417,34M | 725,23M | 621,20M | 581,00M | 635,40M |
| Current Liabilities | 805,48M | 1,17B | 1,18B | 1,06B | 886,29M |